Hippocampal subregion abnormalities in schizophrenia: A systematic review of structural and physiological imaging studies

Neuropsychopharmacology Reports

Volumn 38, Issue 4, 2018, Pages 156-166

  Nakahara, Soichiro ^a,b   Matsumoto, Mitsuyuki ^b   van Erp, Theo G M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ASTELLAS PHARMA INC   (Japan)

Author keywords

CA1; dentate gyrus; hippocampus; psychosis; subfield

Indexed keywords

BRAIN SIZE; DECLARATIVE MEMORY; DENTATE HILUS; DISEASE DURATION; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; HEREDITY; HIGH RISK POPULATION; HIPPOCAMPAL CA1 REGION; HUMAN; MEMORY DISORDER; NEUROIMAGING; NEUROPHYSIOLOGY; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SYSTEMATIC REVIEW; DIAGNOSTIC IMAGING; HIPPOCAMPUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY;

HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; SCHIZOPHRENIA;

EID: 85053754864     PISSN: None     EISSN: 2574173X     Source Type: Journal    
DOI: 10.1002/npr2.12031     Document Type: Review

References (71)

1. Weinberger DR, Berman KF, Suddath R, Torrey EF. Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins. Am J Psychiatry. 1992;149(7):890–7.
2. Weinberger D. Cell biology of the hippocampal formation in schizophrenia. Biol Psychiatry. 1999;45(4):395–402.
3. Heckers S. The hippocampus and schizophrenia. In: Gattaz WF, Häfner H, editors. Search for the causes of schizophrenia. Volume 5. Heidelberg: Steinkopff, 2004; p. 182–200.
4. Haijma SV, Van Haren N, Cahn W, Koolschijn PCMP, Hulshoff Pol HE, Kahn RS. Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects. Schizophr Bull. 2013;39(5):1129–38.
5. van Erp TGM, Hibar DP, Rasmussen JM, et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry. 2016;21(4):585.
6. Okada N, Fukunaga M, Yamashita F, et al. Abnormal asymmetries in subcortical brain volume in schizophrenia. Mol Psychiatry. 2016;21(10):1460–6.
7. Aleman A, Hijman R, de Haan EH, Kahn RS. Memory impairment in schizophrenia: a meta-analysis. Am J Psychiatry. 1999;156(9):1358–66.
8. Leavitt VM, Goldberg TE. Episodic memory in schizophrenia. Neuropsychol Rev. 2009;19(3):312–23.
9. Heckers S, Rauch SL, Goff D, et al. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nat Neurosci. 1998;1(4):318–23.
10. Achim AM. Episodic memory-related activation in schizophrenia: meta-analysis. Br J Psychiatry. 2005;187(6):500–9.
11. Kraguljac NV, Srivastava A, Lahti AC. Memory deficits in schizophrenia: a selective review of functional magnetic resonance imaging (FMRI) studies. Behav Sci. 2013;3(3):330–47.
12. Boos HBM, Aleman A, Cahn W, Hulshoff Pol H, Kahn RS. Brain volumes in relatives of patients with schizophrenia: a meta-analysis. Arch Gen Psychiatry. 2007;64(3):297–304.
13. Whyte M-C, McIntosh AM, Johnstone EC, Lawrie SM. Declarative memory in unaffected adult relatives of patients with schizophrenia: a systematic review and meta-analysis. Schizophr Res. 2005;78(1):13–26.
14. Sitskoorn MM, Aleman A, Ebisch SJH, Appels MCM, Kahn RS. Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis. Schizophr Res. 2004;71(2–3):285–95.
15. Pirnia T, Woods RP, Hamilton LS, et al. Hippocampal dysfunction during declarative memory encoding in schizophrenia and effects of genetic liability. Schizophr Res. 2015;161(2–3):357–66.
16. Velakoulis D, Wood SJ, Wong MTH, et al. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch Gen Psychiatry. 2006;63(2):139–49.
17. Kraguljac NV, White DM, Hadley N, et al. Aberrant hippocampal connectivity in unmedicated patients with schizophrenia and effects of antipsychotic medication: a longitudinal resting state functional MRI study. Schizophr Bull. 2016;42(4):1046–55.
18. Ragland JD, Layher E, Hannula DE, et al. Impact of schizophrenia on anterior and posterior hippocampus during memory for complex scenes. Neuroimage Clin. 2017;13:82–8.
19. Strange BA, Witter MP, Lein ES, Moser EI. Functional organization of the hippocampal longitudinal axis. Nat Rev Neurosci. 2014;15(10):655–69.
20. Small SA, Schobel SA, Buxton RB, Witter MP, Barnes CA. A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat Rev Neurosci. 2011;12(10):585–601.
21. Benes FM. Evidence for altered trisynaptic circuitry in schizophrenic hippocampus. Biol Psychiatry. 1999;46(5):589–99.
22. Lisman JE, Grace AA. The hippocampal-VTA loop: controlling the entry of information into long-term memory. Neuron. 2005;46(5):703–13.
23. Behrendt R-P. Contribution of hippocampal region CA3 to consciousness and schizophrenic hallucinations. Neurosci Biobehav Rev. 2010;34(8):1121–36.
24. Tamminga CA, Stan AD, Wagner AD. The hippocampal formation in schizophrenia. Am J Psychiatry. 2010;167(10):1178–93.
25. Tamminga CA. Psychosis is emerging as a learning and memory disorder. Neuropsychopharmacology. 2013;38(1):247.
26. Van Leemput K, Bakkour A, Benner T, et al. Model-based segmentation of hippocampal subfields in ultra-high resolution in vivo MRI. Med Image Comput Comput Assist Interv. 2008;11(Pt 1):235–43.
27. Kühn S, Musso F, Mobascher A, Warbrick T, Winterer G, Gallinat J. Hippocampal subfields predict positive symptoms in schizophrenia: first evidence from brain morphometry. Transl Psychiatry. 2012;2:e127.
28. Francis AN, Seidman LJ, Tandon N, et al. Reduced subicular subdivisions of the hippocampal formation and verbal declarative memory impairments in young relatives at risk for schizophrenia. Schizophr Res. 2013;151(1–3):154–7.
29. Kirov II, Hardy CJ, Matsuda K, et al. In vivo 7 Tesla imaging of the dentate granule cell layer in schizophrenia. Schizophr Res. 2013;147(2–3):362–7.
30. Mathew I, Gardin TM, Tandon N, et al. Medial temporal lobe structures and hippocampal subfields in psychotic disorders: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. JAMA Psychiatry. 2014;71(7):769–77.
31. Kawano M, Sawada K, Shimodera S, et al. Hippocampal subfield volumes in first episode and chronic schizophrenia. PLoS ONE. 2015;10(2):e0117785.
32. Haukvik UK, Westlye LT, Mørch-Johnsen L, et al. In vivo hippocampal subfield volumes in schizophrenia and bipolar disorder. Biol Psychiatry. 2015;77(6):581–8.
33. Hýža M, Kuhn M, Češková E, Ustohal L, Kašpárek T. Hippocampal volume in first-episode schizophrenia and longitudinal course of the illness. World J Biol Psychiatry. 2016;17(6):429–38.
34. Ota M, Sato N, Hidese S, et al. Structural differences in hippocampal subfields among schizophrenia patients, major depressive disorder patients, and healthy subjects. Psychiatry Res Neuroimaging. 2017;259:54–9.
35. Ho NF, Holt DJ, Cheung M, et al. Progressive decline in hippocampal CA1 volume in individuals at ultra-high-risk for psychosis who do not remit: findings from the longitudinal youth at risk study. Neuropsychopharmacology. 2017;42(6):1361–70.
36. Ho NF, Iglesias JE, Sum MY, et al. Progression from selective to general involvement of hippocampal subfields in schizophrenia. Mol Psychiatry. 2017;22(1):142–52.
37. Rhindress K, Robinson DG, Gallego JA, Wellington R, Malhotra AK, Szeszko PR. Hippocampal subregion volume changes associated with antipsychotic treatment in first-episode psychosis. Psychol Med. 2017;47(10):1706–18.
38. Papiol S, Popovic D, Keeser D, et al. Polygenic risk has an impact on the structural plasticity of hippocampal subfields during aerobic exercise combined with cognitive remediation in multi-episode schizophrenia. Transl Psychiatry. 2017;7(6):e1159.
39. Baglivo V, Cao B, Mwangi B, et al. Hippocampal subfield volumes in patients with first-episode psychosis. Schizophr Bull. 2018;44(3):552–9.
40. Schobel SA, Lewandowski NM, Corcoran CM, et al. Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders. Arch Gen Psychiatry. 2009;66(9):938–46.
41. Schobel SA, Chaudhury NH, Khan UA, et al. Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver. Neuron. 2013;78(1):81–93.
42. Talati P, Rane S, Kose S, et al. Increased hippocampal CA1 cerebral blood volume in schizophrenia. Neuroimage Clin. 2014;5:359–64.
43. Wisse LEM, Gerritsen L, Zwanenburg JJM, et al. Subfields of the hippocampal formation at 7T MRI: in vivo volumetric assessment. NeuroImage. 2012;61(4):1043–9.
44. Yushkevich PA, Amaral RSC, Augustinack JC, et al. Quantitative comparison of 21 protocols for labeling hippocampal subfields and parahippocampal subregions in in vivo MRI: towards a harmonized segmentation protocol. NeuroImage. 2015;111:526–41.
45. Dill V, Franco AR, Pinho MS. Automated methods for hippocampus segmentation: the evolution and a review of the state of the art. Neuroinformatics. 2015;13(2):133–50.
46. Van Leemput K, Bakkour A, Benner T, et al. Automated Segmentation of Hippocampal Subfields from ultra-high resolution in vivo MRI. Hippocampus. 2009;19(6):549–57.
47. Fischl B, Salat D, Kennedy D, et al. Automatic segmentation of the structures in the human brain. NeuroImage. 2001;13(6):118.
48. Fischl B. FreeSurfer. NeuroImage. 2012;62(2):774–81.
49. Iglesias JE, Augustinack JC, Nguyen K, et al. A computational atlas of the hippocampal formation using ex vivo, ultra-high resolution MRI: application to adaptive segmentation of in vivo MRI. NeuroImage. 2015;115:117–37.
50. Wisse LEM, Biessels GJ, Geerlings MI. A critical appraisal of the hippocampal subfield segmentation package in FreeSurfer. Front Aging Neurosci. 2014;6:261.
51. Yushkevich PA, Wang H, Pluta J, et al. Nearly automatic segmentation of hippocampal subfields in in vivo focal T2-weighted MRI. NeuroImage. 2010;53(4):1208–24.
52. Yushkevich PA, Pluta JB, Wang H, et al. Automated volumetry and regional thickness analysis of hippocampal subfields and medial temporal cortical structures in mild cognitive impairment. Hum Brain Mapp. 2015;36(1):258–87.
53. Francis AN, Seidman LJ, Jabbar GA, et al. Alterations in brain structures underlying language function in young adults at high familial risk for schizophrenia. Schizophr Res. 2012;141(1):65–71.
54. Hajek T, Kopecek M, Höschl C, Alda M. Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: a meta-analysis. J Psychiatry Neurosci. 2012;37(5):333–43.
55. Bearden CE, Thompson PM, Dalwani M, et al. Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biol Psychiatry. 2007;62(1):7–16.
56. Keefe R. The brief assessment of cognition in schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res. 2004;68(2–3):283–97.
57. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511(7510):421–7.
58. Whelan CD, Hibar DP, van Velzen LS, et al. Heritability and reliability of automatically segmented human hippocampal formation subregions. NeuroImage. 2016;128:125–37.
59. Greenspan KS, Arakelian CR, van Erp TGM. Heritability of hippocampal formation sub-region volumes. J Neurol Neurosci. 2016;7(6):159.
60. Walton NM, Zhou Y, Kogan JH, et al. Detection of an immature dentate gyrus feature in human schizophrenia/bipolar patients. Transl Psychiatry. 2012;2:e135.
61. Reif A, Fritzen S, Finger M, et al. Neural stem cell proliferation is decreased in schizophrenia, but not in depression. Mol Psychiatry. 2006;11(5):514–22.
62. Goldsmith SK, Joyce JN. Alterations in hippocampal mossy fiber pathway in schizophrenia and Alzheimer's disease. Biol Psychiatry. 1995;37(2):122–6.
63. Konradi C, Yang CK, Zimmerman EI, et al. Hippocampal interneurons are abnormal in schizophrenia. Schizophr Res. 2011;131(1–3):165–73.
64. Benes FM, Lim B, Matzilevich D, Walsh JP, Subburaju S, Minns M. Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars. Proc Natl Acad Sci USA. 2007;104(24):10164–9.
65. Arnold SE, Lee VM, Gur RE, Trojanowski JQ. Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia. Proc Natl Acad Sci USA. 1991;88(23):10850–4.
66. Dwork AJ. Postmortem studies of the hippocampal formation in schizophrenia. Schizophr Bull. 1997;23(3):385–402.
67. Rosoklija G, Toomayan G, Ellis SP, et al. Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders. Arch Gen Psychiatry. 2000;57(4):349.
68. Cotter D, Wilson S, Roberts E, Kerwin R, Everall IP. Increased dendritic MAP2 expression in the hippocampus in schizophrenia. Schizophr Res. 2000;41(2):313–23.
69. van Erp TGM, Walton E, Hibar DP, et al. Cortical brain abnormalities in 4474 individuals with schizophrenia and 5098 control subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) consortium. Biol Psychiatry. 2018; [Epub ahead of print]. https://doi.org/10.1016/j.biopsych.2018.04.023
70. Chang C, Huang C, Zhou N, Li SX, Ver Hoef L, Gao Y. The bumps under the hippocampus. Hum Brain Mapp. 2018;39(1):472–90.
71. Weinberger DR, Radulescu E. Finding the elusive psychiatric “lesion” with 21st-century neuroanatomy: a note of caution. Am J Psychiatry. 2016;173(1):27–33.